Published in J Infect Dis on July 01, 1998
Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl Trop Dis (2011) 1.31
T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment. Am J Trop Med Hyg (2007) 1.14
Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with age. BMC Infect Dis (2007) 1.09
Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni. J Infect Dis (2010) 1.08
IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni. PLoS Pathog (2011) 1.03
Regulatory and activated T cells in human Schistosoma haematobium infections. PLoS One (2011) 1.02
Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status. Parasite Immunol (2010) 1.00
Immunology of human schistosomiasis. Parasite Immunol (2014) 0.99
Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses. BMC Infect Dis (2008) 0.98
Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms. Proc Natl Acad Sci U S A (2012) 0.95
Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment. Infect Immun (1999) 0.95
No apparent reduction in schistosome burden or genetic diversity following four years of school-based mass drug administration in mwea, central kenya, a heavy transmission area. PLoS Negl Trop Dis (2014) 0.89
Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial. J Infect Dis (2008) 0.89
Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons. Infect Immun (1999) 0.88
Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4. Parasite Immunol (2011) 0.88
Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis. PLoS Comput Biol (2011) 0.87
Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium. Sci Rep (2012) 0.87
Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni. Antimicrob Agents Chemother (2008) 0.86
Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel. Clin Vaccine Immunol (2006) 0.86
Chemokines in onchocerciasis patients after a single dose of ivermectin. Clin Exp Immunol (2005) 0.85
Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates. Front Immunol (2015) 0.85
Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases. Front Genet (2014) 0.84
Down-regulation of specific antigen-driven cytokine production in a population with endemic Schistosoma japonicum infection. Clin Exp Immunol (2002) 0.83
Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies. Parasite Immunol (2012) 0.83
Noncirrhotic portal hypertension. J Clin Exp Hepatol (2011) 0.81
Group 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment. PLoS Negl Trop Dis (2015) 0.81
Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection. Malawi Med J (2009) 0.80
Field transmission intensity of Schistosoma japonicum measured by basic reproduction ratio from modified Barbour's model. Parasit Vectors (2013) 0.80
CD16 expression on monocytes in healthy individuals but not schistosome-infected patients is positively associated with levels of parasite-specific IgG and IgG1. PLoS Negl Trop Dis (2014) 0.79
Down Regulation of the TCR Complex CD3ζ-Chain on CD3+ T Cells: A Potential Mechanism for Helminth-Mediated Immune Modulation. Front Immunol (2015) 0.79
Vaccination by delayed treatment of infection. Vaccine (2011) 0.78
Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni. Parasitology (2011) 0.78
Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins. PLoS Negl Trop Dis (2014) 0.78
Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium. PLoS Negl Trop Dis (2014) 0.77
Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration. Clin Infect Dis (2016) 0.77
Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection. J Trop Med (2013) 0.76
Human schistosome infection and allergic sensitisation. J Parasitol Res (2012) 0.75
Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci (2001) 13.64
Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A (1997) 9.07
Dynamics of the 2001 UK foot and mouth epidemic: stochastic dispersal in a heterogeneous landscape. Science (2001) 8.93
Transmission dynamics and epidemiology of BSE in British cattle. Nature (1996) 6.15
The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda. Lancet (2001) 3.42
HIV infection and reproductive health in teenage women orphaned and made vulnerable by AIDS in Zimbabwe. AIDS Care (2005) 2.89
Endemic stability--a veterinary idea applied to human public health. Lancet (2001) 2.67
Immunity in human schistosomiasis. Parasitol Today (1987) 2.55
The epidemiology of BSE in cattle herds in Great Britain. II. Model construction and analysis of transmission dynamics. Philos Trans R Soc Lond B Biol Sci (1997) 2.22
The burden of polyparasitism among primary schoolchildren in rural and farming areas in Zimbabwe. Trans R Soc Trop Med Hyg (2008) 2.05
Biology of African trypanosomes in the tsetse fly. Biol Cell (1988) 1.97
Apostles and Zionists: the influence of religion on demographic change in rural Zimbabwe. Popul Stud (Camb) (1999) 1.82
Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology (2009) 1.74
The dynamics of antigenic variation and growth of African trypanosomes. Parasitol Today (1991) 1.67
Parasite-host coevolution and geographic patterns of parasite infectivity and host susceptibility. Proc Biol Sci (1996) 1.61
A rural HIV epidemic in Zimbabwe? Findings from a population-based survey. Int J STD AIDS (2001) 1.53
The epidemiology of BSE in cattle herds in Great Britain. I. Epidemiological processes, demography of cattle and approaches to control by culling. Philos Trans R Soc Lond B Biol Sci (1997) 1.50
Acquired immunity and epidemiology of Schistosoma haematobium. Nature (1991) 1.44
Failure to transilluminate the stomach is not an absolute contraindication to PEG insertion. Endoscopy (1998) 1.44
Resistance to reinfection after treatment of urinary schistosomiasis. Trans R Soc Trop Med Hyg (1987) 1.44
Malaria parasites undergo antigenic variation at high rates in vivo. Proc Biol Sci (1994) 1.41
A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection. Parasite Immunol (1997) 1.40
Deletion of a novel protein kinase with PX and FYVE-related domains increases the rate of differentiation of Trypanosoma brucei. Mol Microbiol (2001) 1.40
Human immunity to schistosomes. Parasitol Today (1995) 1.39
European malaria vaccine initiative. Parasitol Today (1999) 1.38
Vector-borne diseases and the basic reproduction number: a case study of African horse sickness. Med Vet Entomol (1996) 1.36
Heterogeneities in schistosome transmission dynamics and control. Parasitology (1998) 1.33
Minisatellite marker analysis of Trypanosoma brucei: reconciliation of clonal, panmictic, and epidemic population genetic structures. Proc Natl Acad Sci U S A (2000) 1.33
Prevalence and intensity of intestinal parasitic infections in relation to nutritional status in Mexican schoolchildren. Trans R Soc Trop Med Hyg (2004) 1.32
Structure-activity relationships of various bisphosphonates. Calcif Tissue Int (1983) 1.31
Heterogeneities in water contact patterns and the epidemiology of Schistosoma haematobium. Parasitology (1991) 1.31
Risk factors for HIV infection in a rural cohort in Zimbabwe: a pilot study. Cent Afr J Med (1997) 1.29
Seeking the ghost of worms past. Nat Med (1999) 1.29
Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans R Soc Trop Med Hyg (2008) 1.29
Is there evidence for behaviour change in response to AIDS in rural Zimbabwe? Soc Sci Med (1998) 1.26
Heterogeneities in transmission rates and the epidemiology of schistosome infection. Proc Biol Sci (1991) 1.25
Estimation of the basic reproduction number of BSE: the intensity of transmission in British cattle. Proc Biol Sci (1999) 1.25
The epidemiology and population biology of Necator americanus infection in a rural community in Zimbabwe. Trans R Soc Trop Med Hyg (1992) 1.24
Spatial and temporal heterogeneity in the population dynamics of Bulinus globosus and Biomphalaria pfeifferi and in the epidemiology of their infection with schistosomes. Parasitology (1989) 1.24
Consequences of polyparasitism on anaemia among primary school children in Zimbabwe. Acta Trop (2010) 1.23
Gene discovery in Plasmodium chabaudi by genome survey sequencing. Mol Biochem Parasitol (2001) 1.22
An analysis of foot-and-mouth-disease epidemics in the UK. IMA J Math Appl Med Biol (1997) 1.22
Geographic compatibility of the freshwater snail Bulinus globosus and schistosomes from the Zimbabwe highveld. Int J Parasitol (1995) 1.21
A high level of mixed Trypanosoma brucei infections in tsetse flies detected by three hypervariable minisatellites. Mol Biochem Parasitol (1999) 1.20
Characterisation of the growth and differentiation in vivo and in vitro-of bloodstream-form Trypanosoma brucei strain TREU 927. Mol Biochem Parasitol (2001) 1.18
Analysis of ploidy (in megabase chromosomes) in Trypanosoma brucei after genetic exchange. Mol Biochem Parasitol (1999) 1.15
The basic reproduction number for scrapie. Proc Biol Sci (1999) 1.14
Comparison of the effects of immune killing mechanisms on Trypanosoma brucei parasites of slender and stumpy morphology. Parasite Immunol (1993) 1.12
Cytokines and perinatal brain injury. Neurochem Int (1997) 1.12
Quantification of parasite aggregation: a simulation study. Acta Trop (1993) 1.10
Prevalence of urinary schistosomiasis and HIV in females living in a rural community of Zimbabwe: does age matter? Trans R Soc Trop Med Hyg (2006) 1.10
Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe. Parasite Immunol (1996) 1.09
Exposure, infection and immune responses to Schistosoma haematobium in young children. Parasitology (2000) 1.08
T-Cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase. Infect Immun (1999) 1.07
Onset of expression of the variant surface glycoproteins of Trypanosoma brucei in the tsetse fly studied using immunoelectron microscopy. J Cell Sci (1987) 1.06
Corticotrophin-releasing hormone (CRH)-binding protein interference with CRH antibody binding: implications for direct CRH immunoassay. J Endocrinol (1995) 1.06
Factors affecting the intensity of reinfection with Schistosoma haematobium following treatment with praziquantel. Parasitology (1991) 1.04
Efficacy of mosquito coils containing 0.3% and 0.4% pyrethrins against An.gambiae sensu lato mosquitoes. Cent Afr J Med (1998) 1.04
Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites. Exp Parasitol (1997) 1.04
Towards control of schistosomiasis in sub-Saharan Africa. J Helminthol (2005) 1.04
A mathematical model of the dynamics of scrapie in a sheep flock. Math Biosci (1998) 1.04
Intestinal parasite burden in five troops of olive baboons (Papio cynocephalus anubis) in Gombe Stream National Park, Tanzania. Parasitology (1996) 1.03
Gene exchange in African trypanosomes: frequency and allelic segregation. Mol Biochem Parasitol (1989) 1.03
On the distribution of schistosome infections among host snails. Int J Parasitol (1990) 1.03
Self-fertilisation in Trypanosoma brucei. Mol Biochem Parasitol (1997) 1.03
Host-parasite population genetics: a cross-sectional comparison of Bulinus globosus and Schistosoma haematobium. Parasitology (1999) 1.02
Population dynamics of a scrapie outbreak. Arch Virol (2001) 1.02
Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status. Parasite Immunol (2010) 1.00
Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis. Trans R Soc Trop Med Hyg (2008) 1.00
Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol (1985) 1.00
A genetic interpretation of heightened risk of BSE in offspring of affected dams. Proc Biol Sci (1997) 0.98
Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses. BMC Infect Dis (2008) 0.98
Recent upturn in mortality in rural Zimbabwe: evidence for an early demographic impact of HIV-1 infection? AIDS (1997) 0.98
Aggregation and distribution of strains in microparasites. Philos Trans R Soc Lond B Biol Sci (1999) 0.98
Amplified restriction fragment length polymorphism in parasite genetics. Parasitol Today (2000) 0.97
Anti-schistosome antibody responses in children coinfected with malaria. Parasite Immunol (2000) 0.97
Simulation studies of African horse sickness and Culicoides imicola (Diptera:Ceratopogonidae). J Med Entomol (1996) 0.96
Human schistosomiasis: potential long-term consequences of vaccination programmes. Vaccine (1997) 0.96
Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation (2004) 0.96
Molecular cloning and characterisation of the 22-kilodalton adult Schistosoma mansoni antigen recognised by antibodies from mice protectively vaccinated with isolated tegumental surface membranes. Mol Biochem Parasitol (1991) 0.96
Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium. Mem Inst Oswaldo Cruz (2007) 0.96
What is antibiotic resistance and how can we measure it? Trends Microbiol (2000) 0.95
Prospective randomized controlled trial of urethral versus suprapubic catheterization. Br J Surg (1987) 0.94
Structure of the gene encoding a putative Schistosoma mansoni tegumental antigen precursor. Mol Biochem Parasitol (1993) 0.94
Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoni. Parasite Immunol (1997) 0.94
Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis. Parasite Immunol (2010) 0.94
Population dynamics model for Bulinus globosus, intermediate host for Schistosoma haematobium, in river habitats. Acta Trop (1990) 0.93
Epidemiological features of epidemic cholera (El Tor) in Zimbabwe. Trans R Soc Trop Med Hyg (1996) 0.92
The population genetics of Trypanosoma brucei and the origin of human infectivity. Philos Trans R Soc Lond B Biol Sci (2001) 0.92
The impact of zinc supplementation on growth and body composition: a randomized, controlled trial among rural Zimbabwean schoolchildren. Eur J Clin Nutr (1997) 0.92
P2Y receptors present in the native and isolated rat glomerulus. Nephron Physiol (2004) 0.91